Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

Celebrating National Nurses Week:
What Matters Most to Those with Serious Illness (FREE)

Funding Disclosure: No commercial funding has been accepted for the activity.

Date and Time: May 9, 2018, 11:00 AM – 12:00 PM ET (Live)

Location: Online at

Nurse Amy Berman, Senior Program Officer
Speaker Name and Title:
Amy Berman, RN, LHD, FAAN
Senior Program Officer
The John A. Hartford Foundation

Purpose: The goal of this webinar is to help nurses improve their understanding of palliative care, enhance their ability to be of value to seriously ill patients, and to be more focused on the needs of their patients.

Why Do I Need to Know This?
We live in an aging nation and world. More people will experience serious illness and it is possible to help people live well in the face of serious illness, get the care they want, and avoid the care they don’t want. But, this is only possible with your help. 


  1. Participants will be able to articulate three goals of seriously ill older patients
  2. Participants will identify palliative care’s role in curative care, chronic care, and at end of life
  3. Participants will recognize three components of advance care planning

Target Audience: Nursing administrators and managers, nurses, and healthcare coaches

Criteria for Successful Completion:

  1. Attendance at entire session
  2. Submission of completed evaluation form

Continuing Education Credits: 1.0

Continuing Education Accreditation:

Nurses:  MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


System Requirements for Computers and Mobile Devices:

Amy Berman, RN, LHD, FAAN, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with Tabula Rasa for research support.

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA